Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/20/2003CA2208013C Recombinant dna molecules and expression vectors for erythropoietin
05/20/2003CA2197302C Solid support reagents for the synthesis of 3'-nitrogen containing polynucleotides
05/20/2003CA2160166C Lactic acid bacterial suppressor mutants and their use as selective markers and as means of containment in lactic acid bacteria
05/20/2003CA2131551C Conjugates formed from heat shock proteins and oligo- or polysaccharides
05/20/2003CA2123416C Process for producing/secreting a protein by a transformed mould using expression/secretion regulating regions derived from an aspergillus endoxylanase ii gene
05/20/2003CA2102302C Recombinant defective adenoviruses expressing cytokines for an antitumoral treatment
05/20/2003CA2078043C Biotin operon
05/20/2003CA2075695C Monoclonal antibodies to sulfonated polymers
05/16/2003CA2408977A1 Method for producing dna
05/16/2003CA2407575A1 Oligonucleotide-immobilized substrate for detecting methylation
05/15/2003WO2003041128A2 Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
05/15/2003WO2003040726A2 Screening for hepatitis c virus entry inhibitors
05/15/2003WO2003040695A2 Protein knobs
05/15/2003WO2003040694A2 Enzymatic cycling assays for homocysteine and cystathionine
05/15/2003WO2003040689A2 Compositions, methods and kits for determining the presence of mycoplasma pneumoniae and/or mycoplasma genitalium in a test sample
05/15/2003WO2003040687A2 Isolation and purification of nucleic acids
05/15/2003WO2003040681A2 Genes coding for metabolic pathway proteins
05/15/2003WO2003040414A1 Method and device for detecting and monitoring alcoholism and related diseases using microarrays
05/15/2003WO2003040411A1 Methods, systems, and kits for analysis of polynucleotides
05/15/2003WO2003040408A2 Detection of predisposition to osteoporosis
05/15/2003WO2003040403A1 Functional assay for genes involved in xylogenesis
05/15/2003WO2003040396A2 Polynucleotide and polypeptide sequences of monkey cathepsins
05/15/2003WO2003040395A2 Universal nucleotides for nucleic acid analysis
05/15/2003WO2003040394A2 Production of recombinant proteins in vivo and use for generating antibodies
05/15/2003WO2003040391A2 Method for producing and identifying soluble protein domains
05/15/2003WO2003040388A2 Method for detecting bacteria associated with parodontitis and tooth decay
05/15/2003WO2003040384A1 Recombinant antibodies for the detection and neutralization of anthrax toxin
05/15/2003WO2003040379A2 Modulating urea degradation in wine yeast
05/15/2003WO2003040378A1 Method of plant transformation
05/15/2003WO2003040377A1 Method fro selecting genetically transformed cells
05/15/2003WO2003040376A1 Method for site-directed mutagenesis of nucleic acid molecules using a single primer
05/15/2003WO2003040375A1 COMPOSITIONS AND PROCESSES USING siRNA, AMPHIPATHIC COMPOUNDS AND POLYCATIONS
05/15/2003WO2003040374A1 METHODS AND COMPOSITIONS FOR ENHANCED PROTEIN EXPRESSION AND/OR GROWTH OF CULTURED CELLS USING CO-TRANSCRIPTION OF A Bcl2 ENCODING NUCLEIC ACID
05/15/2003WO2003040373A2 Production of l-lysine by genetically modified corynebacterium glutamicum strains
05/15/2003WO2003040372A2 Polynucleotides and polypeptides involved in clavulinic acid biosynthesis and use thereof
05/15/2003WO2003040371A1 Novel g protein-coupled receptor protein and dna thereof
05/15/2003WO2003040370A1 Weed controller metabolism proteins, genes thereof and use of the same
05/15/2003WO2003040369A2 Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines
05/15/2003WO2003040368A2 Pharmaceutical compositions of marine sponge microciona prolifera
05/15/2003WO2003040366A2 Inhibitor oligonucleotides and their use for specific repression of a gene
05/15/2003WO2003040365A2 Pna-conjugate or pna-conjugate mixture for treating diseases related to the human papillomavirus
05/15/2003WO2003040364A1 Method for the isolation of nucleic acids
05/15/2003WO2003040363A1 Rice transposon genes
05/15/2003WO2003040362A1 Gene transfer vector composition
05/15/2003WO2003040360A1 Methods of storing and/or delivering an oligomer and/or polymer applied on a support, and supports thereof
05/15/2003WO2003040359A1 Preparing somatic embryo by utilizing rabbit oocyte
05/15/2003WO2003040358A1 Somatic cell derived embryonic stem cells and its differentiated cells
05/15/2003WO2003040357A2 Genes coding for phosphoenolpyruvate-sugar-phosphotransferase proteins
05/15/2003WO2003040353A1 A novel stem cell with long-term growth potential, methods of culturing and animals derived therefrom
05/15/2003WO2003040352A1 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted
05/15/2003WO2003040345A2 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003WO2003040344A2 Transcription factor stress-related polypeptides and methods of use in plants
05/15/2003WO2003040343A2 Polynucleotide and polypeptide sequences of canine cathepsin s
05/15/2003WO2003040342A2 Method for generation of modular polynucleotides using solid supports
05/15/2003WO2003040339A2 Antisense modulation of purinoreceptor p2x¿3?
05/15/2003WO2003040337A2 Polyamide modulators of cox2 transcription
05/15/2003WO2003040335A2 Engineering of leader peptides for the secretion of recombinant proteins in bacteria
05/15/2003WO2003040334A2 Methods for the identification of inhibitors of 4-coumarate-coa ligase expression or activity in plants
05/15/2003WO2003040333A2 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
05/15/2003WO2003040329A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003WO2003040328A2 Antisense modulation of thyroid hormone receptor interactor 6 expression
05/15/2003WO2003040324A2 Methods for mutating genes in cells and animals using insertional mutagenesis
05/15/2003WO2003040323A2 Bacterial ion channel and a method for screening ion channel modulators
05/15/2003WO2003040322A2 Promoters for regulation of gene expression in plant roots
05/15/2003WO2003040321A2 Antisense modulation of eif2c1 expression
05/15/2003WO2003040320A2 Antisense modulation of human collapsin response mediator protein 2 expression
05/15/2003WO2003040318A2 Method and system for inducible recombinational cloning in bacterial cells
05/15/2003WO2003040317A2 Lung cancer therapeutics and diagnostics
05/15/2003WO2003040314A2 E1-revertant-free adenoviral composition
05/15/2003WO2003040313A2 Il-21 antagonists
05/15/2003WO2003040310A2 Novel epidermal growth factor protein and gene, and methods of use therefor
05/15/2003WO2003040309A2 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
05/15/2003WO2003040307A2 Heteromultimeric tnf ligand family members
05/15/2003WO2003040306A2 Compositions from the grasses lolium perenne and festuca arundinacea
05/15/2003WO2003040305A2 Porcine adenovirus e1 and e4 regions
05/15/2003WO2003040304A2 Method of proliferation in neurogenic regions
05/15/2003WO2003040303A2 Functional assay for agonist activation of receptors
05/15/2003WO2003040299A2 Method of selecting hla-dp4 ligands and the applications thereof
05/15/2003WO2003040297A2 New protein of the defensin family from oil palm
05/15/2003WO2003040296A2 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003040295A2 Ion channel
05/15/2003WO2003040294A2 METHOD FOR THE IN VITRO SYNTHESIS OF SHORT DOUBLE STRANDED RNAs
05/15/2003WO2003040293A2 Genes coding for stress resistance and tolerance proteins
05/15/2003WO2003040292A2 Genes encoding for membrane synthesis and membrane transport proteins
05/15/2003WO2003040289A2 Genes coding for dna replication proteins and for proteins related to pathogenesis
05/15/2003WO2003040286A2 Cdw92 molecule induced immunomodulation
05/15/2003WO2003040188A1 Antibody stimulating il-1ra production
05/15/2003WO2003040187A1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
05/15/2003WO2003040184A1 Novel protein and dna thereof
05/15/2003WO2003040183A2 Compounds for the diagnosis/prevention/treatment of alzheimer's disease
05/15/2003WO2003040182A1 Antisense oligonucleotides modulating bcl-2 expression
05/15/2003WO2003040181A2 Genes from the corynebacterium glutamicum coding for regulatory proteins
05/15/2003WO2003040171A2 Protein kinase stress-related polypeptides and methods of use in plants
05/15/2003WO2003040170A2 Antibodies to cd40
05/15/2003WO2003040168A2 Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
05/15/2003WO2003040167A2 Peptides which deliver antisense oligonucleotides and downregulate protein expression in cells
05/15/2003WO2003040164A2 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003WO2003040161A2 Antisense modulation of activating transcription factor 3 expression
05/15/2003WO2003040100A1 Compositions, methods and kits pertaining to luminescent compounds
05/15/2003WO2003039703A2 Method in the form of a dry rapid test for detecting nucleic acids